Top

News & Events

Instinctif Partners Congratulates the Shortlisted Nominees for the Lifestars Awards 2018

Instinctif Partners Congratulates the Shortlisted Nominees for the Lifestars Awards 2018

London, UK, 28 September 2018 – Instinctif Partners, the business communications consultancy, congratulates all of the nominees shortlisted as finalists for the Lifestars Awards 2018 (in association with Jefferies). The Lifestars Awards is an international event with attendance of over 500 global life science leaders, investors and deal makers, and key stakeholders. The awards commemorates the successes of key industry players across Europe and the US over the last 12 months.

Congratulations goes to the 11 clients of Instinctif Partners Life Sciences’ practice who have been selected as finalists across 8 of the total 16 highly coveted awards. These are:

EU Private Finance Raise of the Year
     (<£30m)

  • Agendia, The Netherlands
  • NorthSea Therapeutics, The Netherlands

     (>£30m)

  • Crescendo Biologics, UK
  • Hookipa Biotech, Austria
  • Immatics Biotechnologies, Germany

Deal of the Year (European HQ)

  • F-Star (with Denali Therapeutics)
  • Hookipa Biotech (with Gilead)
  • Immatics Biotechnologies (with Genmab)
  • Microbiotica and Roche (with Genentech)


Pharma/Large Biotech BD Team of the Year

  • Roche/Genentech


Market Approval of the Year

  • Novartis/Astex - Kisqali
  • Roche/Genentech - Actemra and Hemlibra EU Private Company of the Year
  • Crescendo Biologics, UK
  • F-Star, UK
  • Hookipa Biotech, Austria
  • Microbiotica, UK


EU Investment Firm of the Year

  • Forbion
  • Medicxi


Pharma/Large Cap Biotech of the Year

  • Roche/Genentech


Private CEO of the Year

  • Jӧrn Aldag, Hookipa Biotech
  • Harpreet Singh, Immatics Biotechnologies


The shortlisted companies in each category will be reviewed by an 80-strong judging panel, composed of a diverse group of experienced individuals. The winners will then be revealed at the Lifestars Gala Dinner and awards evening held on Tuesday 13 November at The Honourable Artillery Company in London, in support of UNICEF UK as the official charity beneficiary. The event will be held on the evening of the LSX (formerly known as Biotech and Money) and Jefferies Inv€$tival Showcase.

The full list of award categories and finalists, as well as further information on the awards dinner can be found here.

Commenting on the announcement of the finalists, Sue Charles, Managing Partner of Instinctif Partners Life Sciences’ practice and member of the judging panel said:

“Our Life Sciences clients have had an incredibly strong year and the Lifestars Awards are a great opportunity to recognise their contributions to the sector. We thank them for choosing to work with us to help drive their communications and we are delighted to see so many shortlisted in this year’s awards, as a reflection of their achievements.”

 

About Instinctif Partners Life Sciences

Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences practice has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.



People


Sue Charles
Managing Partner


Sue Charles
Managing Partner